missing translation for 'onlineSavingsMsg'
Learn More
Learn More
(2S)-2-[(3S,5aS,8aS,9aS)-3-Methyl-1,4-dioxodecahydro-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-2-yl]-4-phenylbutanoic Acid (Ramipril Diketopiperazine Acid), Mikromol™
Description
(2S)-2-[(3S,5aS,8aS,9aS)-3-Methyl-1,4-dioxodecahydro-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-2-yl]-4-phenylbutanoic Acid (Ramipril Diketopiperazine Acid)
Specifications
Specifications
| Chemical Name or Material | Ramiprilat Diketopiperazine |
| CAS | 108736-10-3 |
| Analyte or Component Names | Ramiprilat Diketopiperazine |
| Shipping Condition | Room Temperature |
| Molecular Formula | C21 H26 N2 O4 |
| Certifications/Compliance | ISO 17025 |
| Synonym | (2S)-2-[(3S,5aS,8aS,9aS)-3-methyl-1,4-dioxodecahydro-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-2-yl]-4-phenylbutanoic acid, Ramipril Diketopiperazine Acid, Ramipril Imp. K (EP), (alphaS,3S,5aS,8aS,9aS)-Decahydro-3-methyl-1,4-dioxo-alpha-(2-phenylethyl)-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazine-2-acetic Acid, 2H-Cyclopenta[4,5]pyrrolo[1,2-a]pyrazine-2-acetic acid, decahydro-3-methyl-1,4-dioxo-alpha-(2-phenylethyl)-, [3S-[2(R*),3alpha,5abeta,8abeta,9abeta]]- (9CI), (alphaS,3S,5aS,8aS,9aS)-Decahydro-3-methyl-1,4-dioxo-alpha-(2-phenylethyl)-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazine-2-acetic acid, Ramipril Impurity K |
| InChI Formula | InChI=1S/C21H26N2O4/c1-13-19(24)23-16-9-5-8-15(16)12-18(23)20(25)22(13)17(21(26)27)11-10-14-6-3-2-4-7-14/h2-4,6-7,13,15-18H,5,8-12H2,1H3,(H,26,27)/t13-,15-,16-,17-,18-/m0/s1 |
| SMILES | C[C@@H]1N([C@@H](CCc2ccccc2)C(=O)O)C(=O)[C@@H]3C[C@@H]4CCC[C@@H]4N3C1=O |
| IUPAC Name | (2S)-2-[(2S,4aS,5aS,8aS)-2-methyl-1,4-dioxo-2,4a,5,5a,6,7,8,8a-octahydrocyclopenta[3,4]pyrrolo[3,5-c]pyrazin-3-yl]-4-phenylbutanoic acid |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?